• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者循环 miR-142-3p 水平。

Circulating miR-142-3p levels in patients with systemic sclerosis.

机构信息

Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Honjo, Kumamoto, Japan.

出版信息

Clin Exp Dermatol. 2012 Jan;37(1):34-9. doi: 10.1111/j.1365-2230.2011.04158.x. Epub 2011 Aug 25.

DOI:10.1111/j.1365-2230.2011.04158.x
PMID:21883400
Abstract

BACKGROUND

Recently, increased evidence has shown that serum micro (mi)RNA levels are a useful biomarker for the diagnosis, prognosis and therapeutic value of various diseases. However, serum miRNA has not been investigated in patients with systemic sclerosis (SSc), to our knowledge.

AIM

To investigate the possibility that serum levels of Homo sapiens miR-142 stem-loop (hsa-miR-142-3p), one of the miRNAs regulating the expression of integrin αV, could be a specific disease marker for SSc.

METHODS

Serum samples were obtained from 61 patients with SSc and 20 healthy controls. Patients with systemic lupus erythematosus (SLE), dermatomyositis (DM) and scleroderma spectrum disorder (SSD), who did not fulfil American College of Rheumatology criteria for SSc but might develop SSc in the future, were included as disease controls in this study. miRNAs were purified from serum, and miR-142-3p levels were measured with a quantitative real-time PCR assay.

RESULTS

Serum miR-142-3p levels in patients with SSc were significantly higher than in patients with SSD, SLE or DM, and healthy control groups. Patients with increased miR-142-3p levels tended to have a short sublingual frenulum.

CONCLUSIONS

Our data indicate that serum levels of miR-142-3p may be elevated specifically in patients with SSc, correlating with the severity of this disease, and may be useful diagnostic markers for the presence of SSc and for the differentiation of SSc from SSD.

摘要

背景

最近,越来越多的证据表明血清微小 RNA(miRNA)水平是各种疾病诊断、预后和治疗价值的有用生物标志物。然而,据我们所知,血清 miRNA 尚未在系统性硬化症(SSc)患者中进行研究。

目的

探讨调节整合素 αV 表达的 miRNA 之一——人源 miR-142 茎环(hsa-miR-142-3p)的血清水平是否可能成为 SSc 的特异性疾病标志物。

方法

从 61 例 SSc 患者和 20 名健康对照者中采集血清样本。本研究将系统性红斑狼疮(SLE)、皮肌炎(DM)和硬皮病谱障碍(SSD)患者纳入疾病对照组,这些患者不符合美国风湿病学会 SSc 的诊断标准,但将来可能发展为 SSc。从血清中纯化 miRNA,采用实时定量 PCR 检测 miR-142-3p 水平。

结果

SSc 患者的血清 miR-142-3p 水平明显高于 SSD、SLE 或 DM 患者及健康对照组。miR-142-3p 水平升高的患者舌系带往往较短。

结论

我们的数据表明,血清 miR-142-3p 水平可能特异性升高,与疾病的严重程度相关,并且可能对 SSc 的存在以及 SSc 与 SSD 的鉴别具有诊断价值。

相似文献

1
Circulating miR-142-3p levels in patients with systemic sclerosis.系统性硬化症患者循环 miR-142-3p 水平。
Clin Exp Dermatol. 2012 Jan;37(1):34-9. doi: 10.1111/j.1365-2230.2011.04158.x. Epub 2011 Aug 25.
2
Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.系统性硬皮病患者血清可溶性血管内皮生长因子受体-2 水平。
Br J Dermatol. 2010 Apr;162(4):751-8. doi: 10.1111/j.1365-2133.2009.09567.x. Epub 2009 Nov 3.
3
microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.硬皮病患者血清和真皮成纤维细胞中的 microRNA-92a 表达增加。
Rheumatology (Oxford). 2012 Sep;51(9):1550-6. doi: 10.1093/rheumatology/kes120. Epub 2012 Jun 1.
4
The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.系统性硬化症中循环游离微小RNA谱与健康对照和系统性红斑狼疮均不同。
J Rheumatol. 2015 Feb;42(2):214-21. doi: 10.3899/jrheum.140502. Epub 2014 Nov 15.
5
Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.循环 microRNAs 作为系统性红斑狼疮患者的候选生物标志物。
Transl Res. 2012 Sep;160(3):198-206. doi: 10.1016/j.trsl.2012.04.002. Epub 2012 May 4.
6
Elevation of serum lymphotactin levels in patients with systemic sclerosis.系统性硬化症患者血清淋巴细胞趋化因子水平升高。
J Rheumatol. 2008 May;35(5):834-8. Epub 2008 Mar 1.
7
Serum CCL23 levels are increased in patients with systemic sclerosis.系统性硬化症患者血清 CCL23 水平升高。
Arch Dermatol Res. 2011 Jan;303(1):29-34. doi: 10.1007/s00403-010-1078-8. Epub 2010 Sep 8.
8
Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.系统性硬化症和系统性红斑狼疮中的肿瘤相关抗原:与器官表现、免疫实验室指标及疾病活动指数的关联
J Autoimmun. 2008 Dec;31(4):372-6. doi: 10.1016/j.jaut.2008.08.008. Epub 2008 Oct 15.
9
miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.miR-150 的下调通过诱导整合素 β3 导致硬皮病皮肤成纤维细胞中 I 型胶原的组成性过表达。
Am J Pathol. 2013 Jan;182(1):206-16. doi: 10.1016/j.ajpath.2012.09.023. Epub 2012 Nov 14.
10
Elevated circulating CD40L concentrations in patients with systemic sclerosis.系统性硬化症患者循环中CD40L浓度升高。
J Rheumatol. 2004 Mar;31(3):514-9.

引用本文的文献

1
MicroRNAs in Systemic Sclerosis: Involvement in Disease Pathogenesis and Potential Use as Diagnostic Biomarkers and Therapeutic Targets.系统性硬化症中的微小RNA:参与疾病发病机制及作为诊断生物标志物和治疗靶点的潜在用途。
Biomedicines. 2025 May 16;13(5):1216. doi: 10.3390/biomedicines13051216.
2
A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways.系统性硬化症发病机制的近期研究综述:聚焦纤维化途径
Front Immunol. 2025 Apr 16;16:1551911. doi: 10.3389/fimmu.2025.1551911. eCollection 2025.
3
Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease.
病毒诱导的微小RNA调控与系统性硬化症
Biomedicines. 2024 Jun 19;12(6):1360. doi: 10.3390/biomedicines12061360.
4
Analysis of miRNAs in Caused by Mutations in and : Insights into Molecular Mechanisms and Potential Therapeutic Targets.由[具体基因名称1]和[具体基因名称2]突变引起的[疾病名称]中微小RNA的分析:对分子机制和潜在治疗靶点的见解
Pharmaceuticals (Basel). 2023 Oct 4;16(10):1414. doi: 10.3390/ph16101414.
5
Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?循环微小RNA作为风湿性疾病生物标志物的潜力如何?
Genes Dis. 2022 Sep 7;10(4):1263-1278. doi: 10.1016/j.gendis.2022.08.011. eCollection 2023 Jul.
6
Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets.生物信息学综合筛选系统性硬皮病特异性表达标志物以鉴定治疗靶点。
Front Immunol. 2023 Mar 30;14:1125183. doi: 10.3389/fimmu.2023.1125183. eCollection 2023.
7
Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs.系统性硬化症发病机制的新观念:微小RNA的作用
Biomedicines. 2021 Oct 14;9(10):1471. doi: 10.3390/biomedicines9101471.
8
Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.生物信息学和系统生物学方法鉴定 SARS-CoV-2 感染对特发性肺纤维化和慢性阻塞性肺疾病患者的影响。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab115.
9
Epigenetics in Non-tumor Immune-Mediated Skin Diseases.非肿瘤免疫介导性皮肤病的表观遗传学。
Mol Diagn Ther. 2021 Mar;25(2):137-161. doi: 10.1007/s40291-020-00507-1. Epub 2021 Mar 1.
10
Low expression of miR-142-3p promotes intervertebral disk degeneration.miR-142-3p 低表达促进椎间盘退变。
J Orthop Surg Res. 2021 Jan 14;16(1):55. doi: 10.1186/s13018-020-02194-4.